Intermediate-dose melphalan (IDM) combined with G-CSF (filgrastim) is an effective and safe induction therapy for autologous stem cell transplantation in multiple myeloma

Translated title of the contribution: Intermediate-dose melphalan (IDM) combined with G-CSF (filgrastim) is an effective and safe induction therapy for autologous stem cell transplantation in multiple myeloma

H.M. Lokhorst, P. Sonneveld, P.W. Wijermans, M. van Marwijk Kooy, O.J.A.Th. Meuwissen, R.H.J. van Oers, R. van der Griend, A.W. Dekker

Research output: Contribution to journalArticleAcademicpeer-review

Translated title of the contributionIntermediate-dose melphalan (IDM) combined with G-CSF (filgrastim) is an effective and safe induction therapy for autologous stem cell transplantation in multiple myeloma
Original languageUndefined/Unknown
Pages (from-to)44-48
Number of pages5
JournalBritish Journal of Haematology
Volume92
Publication statusPublished - 1996

Cite this